Physician profile
William Bartley Hosick
NPI 1922051119
$13,350.91
in general payments reported to CMS, 2019-2025
9 companies · $1,129 in 2025
The $1,129 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $17.60 · 2021: $4,632 · 2022: $3,266 · 2023: $1,552 · 2024: $1,385 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,218 · Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,217.57 |
| Food and Beverage | $1,847.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,573.63 | 2019-2025 | Mako, Orthomap, Triathlon |
| Arthrex, INC. | $3,768.94 | 2021-2023 | |
| Depuy Synthes Sales INC. | $999.01 | 2019-2025 | Velys |
| Fortis Surgical, LLC | $699.45 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $141.56 | 2023 | Iovera, Exparel |
| Moximed, INC | $73.63 | 2025 | Misha Knee System, Small, Left |
| Medical Device Business Services, INC. | $64.65 | 2021-2025 | Velys |
| Endo Pharmaceuticals INC. | $16.01 | 2019 | |
| Smith+Nephew, INC. | $14.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hosick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.